|
WO2021018934A1
|
|
Treatment of sebaceous gland disorders
|
|
WO2021018936A1
|
|
Treatment of inflammatory skin conditions
|
|
WO2021018935A1
|
|
Treatment of aging or uv-damaged skin
|
|
EP3274321A1
|
|
Cannabidiol isolate from industrial-hemp and use thereof in pharmaceutical and/or cosmetic preparations
|
|
CN105848646A
|
|
Compressed tablet containing cannabidiol, method for its manufacture and use of such tablet in oral treatment of psychosis or anxiety disorders
|
|
WO2015065180A1
|
|
Compressed tablet containing delta 9-tetrahydrocannabinol, method for its manufacture and use of such tablet in oral treatment
|
|
CA2872528A1
|
|
Cannabis plant isolate comprising .delta.9-tetrahydrocannabinol and a method for preparing such an isolate
|
|
CA2872689A1
|
|
Granulate containing cannabinoid, method for its manufacture and oral dosage unit comprising such granulate
|
|
EP2061427A2
|
|
Granulate containing a pharmaceutically active substance and an emulsifier and method for its manufacture
|
|
CA2664315A1
|
|
Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
|
